Drug-drug Interaction Study Beteewn ASK120067 and Rifampicin or Itraconazole
Status:
Completed
Trial end date:
2022-08-03
Target enrollment:
Participant gender:
Summary
To evaluate the effects of oral administration rifampicin or itraconazole capsules on the
pharmacokinetics of ASK120067 and its metabolite CCB4580030 in healthy subjects.
To evaluate the safety of ASK120067 tablets or combination with rifampicin capsules or
itraconazole capsules in healthy subjects.